Caxton Associates (New York)’s Neogen NEOG Stock Holding History
Bought
Maintained
Sold
Other funds holding NEOG
WA
BCM
CCA
Caxton Associates (New York)'s NEOG Position: Q4 2022 in Review
Caxton Associates (New York) sold out of Neogen (NEOG) in Q4 2022, closing a stake of 66,393 shares — an estimated $928K sold.
Caxton Associates (New York) first reported a position in NEOG in Q3 2021 and held it in 5 quarters. The position peaked at $1.76M in Q2 2022. 370 funds tracked by Wall St. Rank hold NEOG as of Q4 2022.
- Caxton Associates (New York) reported no remaining Neogen position as of Q4 2022 after selling out during the quarter.
- Caxton Associates (New York) sold 66,393 Neogen shares in Q4 2022, an estimated $928K.
- Caxton Associates (New York) first reported a position in Neogen in Q3 2021 and held it in 5 quarters.
- Caxton Associates (New York)'s Neogen position peaked at $1.76M in Q2 2022.
- 370 funds tracked by Wall St. Rank held Neogen as of Q4 2022.
Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.